Gender affirming hormone therapy (GAHT) is used by many transgender people to reduce
gender incongruence and improve psychological functioning. As GAHT shares many …

Endometriosis is a debilitating gynecological condition commonly seen in individuals
designated female at birth; however, there has been limited research focused on its …

Endometriosis, traditionally associated with cisgender women, should be recognized as a
significant issue for transgender men. This perspective highlights the need to address the …

Background Pelvic pain has been reported in transmasculine individuals taking
testosterone. There is a need for further investigation to increase understanding of the …

Introduction The objective of this document is to guide best practice to ensure the safety and
dignity of transgender and gender‐diverse people in the peri‐operative period. While …

Background Testosterone use among transgender people likely impacts their experience of
sexual function and vulvovaginal pain via several complex pathways. Testosterone use is …

Conflicting evidence exists about the risk of breast cancer in transgender and gender-
diverse (TGD) patients treated with testosterone. This review aimed to summarize current …

In brief This manuscript aims to promote an understanding of the special needs of
transgender and gender-diverse people by putting trans gynecology into context. By …

Specific Aim Provide an overview of the literature addressing major areas pertinent to pain
in transgender persons and to identify areas of primary relevance for future research …

Gender‐affirming hormone therapy (GAHT) is used by many transgender and gender‐
diverse adults to align physical characteristics with their gender identity, reduce gender …